At present, most patients who eventually undergo radical or partial nephrectomy do not undergo RMB, whereas most patients who eventually undergo ablation or systemic therapy do. The optimal use of RMB in the evaluation of kidney tumors has yet to be determined.
Most medical research focuses on fighting individual disease. But delayed aging could boost life expectancy by more than two years and yield more than $7 trillion over 50 years. Greater investment in research to delay aging could be a very efficient way to prevent disease, improve public health, and extend healthy life.
Both practice environment and patient clinical and demographic characteristics are associated with cancer clinical trial enrollment; simultaneous intervention may be required when trying to increase enrollment rates.
The objective of this study was to determine how patient preferences guide the course of palliative chemotherapy for advanced colorectal cancer.
The importance of developing personalized risk prediction estimates has become increasingly evident in recent years.
In a Northern Italian population, the absolute risk of lung cancer among never smokers is higher in women than men but among smokers is lower in women than men. Lexpit regression is a novel approach to additive-multiplicative risk modeling that can contribute to clearer interpretation of population-based case–control studies.
Policies to increase preventive testing in developing countries should include subsidies towards treatment costs.
Accurate information regarding race, ethnicity, and national origins is critical for identifying disparities in the cancer burden.
Use of nonrecommended services for surveillance occurs frequently among early-stage breast cancer survivors.
This paper introduces two metrics for IRT DIF evaluation that can discern potentially problematic DIF among items flagged with statistically significant DIF.
A large number of chronic conditions, including cancer, are associated uniquely with decrements in health utility. The cumulative effects of comorbid conditions have substantial impact on daily functioning and well-being of Medicare beneficiaries.
A survey of oncology practice managers was used to obtain quantitative and qualitative data on practice characteristics and treatment patterns.
Few patients 75 years of age and older participate in clinical trials, thus whether adjuvant chemotherapy for stage III colon cancer (CC) benefits this group is unknown.
Health care in the United States is notoriously expensive while often failing to deliver the care recommended in published guidelines.
This chapter presents an overview of computational modeling as a tool for multilevel cancer care and intervention research.
This Statistical Brief presents data from the Healthcare Cost and Utilization Project (HCUP) on hospital stays for cancer care in individuals under 18 years of age in 2009.
There is a growing emphasis on promoting medical treatments that provide the most benefits relative to their costs.
Assessments of the medical and economic value of therapies in diseases such as cancer traditionally focus on average or median gains in patients' survival.
The higher-cost US system of cancer care delivery may be worth it, although further research is required to determine what specific tools or treatments are driving improved cancer survival in the United States.
The addition of oxaliplatin to 5-FU appears to be associated with better survival among patients receiving adjuvant colon cancer treatment in the community.